Literature DB >> 12368750

Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor.

Hans A Brings1, John K Waas, Keith R McCrae, Henry R Baele, Jerry Goldstone.   

Abstract

Acquired factor VIII inhibitor is increasingly recognized as a cause of major soft tissue hemorrhage. The laboratory diagnosis can be obscured by the synchronous presence of the lupus anticoagulant, an extremely rare occurrence that has been reported outside the vascular surgery literature. Vascular surgeons should be knowledgeable of factor VIII inhibitor and aware that it can present with other blood disorders, making the diagnosis more difficult and management more complex. This case report describes such a patient and reviews the current literature on this topic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368750     DOI: 10.1067/mva.2002.127336

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Rare case of acquired haemophilia and lupus anticoagulant.

Authors:  Devika Gupta; Tathagat Chatterjee; Ajay Sharma; Prosenjit Ganguli; Satyaranjan Das; Sanjeevan Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-09       Impact factor: 0.900

2.  Coexistence of Acquired Hemophilia and Antiphospholipid Serology in Monoclonal Gammopathy Patient.

Authors:  Nabil Belfeki; Sarra Hamrouni; Alessio Strazzulla; Sylvain Diamantis
Journal:  Int Med Case Rep J       Date:  2021-04-28

3.  Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report.

Authors:  Victor Chen; Lauren C Roby; Stephanie Wentzel; Mingjia Li; Nicholas Jones
Journal:  J Med Case Rep       Date:  2022-05-03

4.  Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient.

Authors:  Jeremy W Jacobs; Savanah D Gisriel; Krishna Iyer; Henry M Rinder
Journal:  J Thromb Thrombolysis       Date:  2021-10-25       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.